drugset / Trial / NCT05543785

Ketorolac Intravenous Regional Analgesia in Lower Limb Surgeries

NCT05543785

Recruiting 76 enrolled Mansoura University
RandomizedParallel-groupDouble-blindPrevention

Summary

Tourniquet, a compressing device, otherwise its use in intravenous regional anesthesia, is commonly used in particular orthopedic surgeries. From the previous documented effectiveness and safety of intravenous (IV) administration of ketorolac in the circulatory-isolated limb as a part of intravenous regional anesthesia; we hypothesized that in orthopedic surgeries done with tourniquet, intravenous (IV) administration of ketorolac after tourniquet inflation, will act as intravenous regional analgesia. So, it will prolong the postoperative analgesic duration as a primary outcome.

Timeline

Start
2022-11-01
Primary completion
2027-05-30
Completion
2027-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 30 mg Intravenous

Indications

No indication recorded.